Policlinico Universitario Agostino Gemelli at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Policlinico Universitario Agostino Gemelli brings 2 presentations to ISLB 2026 in Madrid. Its work centres on liquid biopsy profiling in breast cancer. One study tracks the circulating tumour DNA response to trastuzumab deruxtecan in metastatic HER2-positive disease, and another weighs the clinical value of broad liquid biopsy profiling in BRCA2-mutated invasive lobular breast cancer.

OrganizationISLB 2026 Attendance
policlinicogemelli.it
Hospitals & cancer centres
Research and teaching hospital of the Catholic University of the Sacred Heart in Rome, Italy.
Poster
Poster

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Policlinico Universitario Agostino Gemelli

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction